ABV is now cash-flow positive and likely profitable in the immediate future.
They have taken the sensible course of action to licence the product where it make sense and given up the ridiculous idea of setting up overseas manufacturing facility, preferring to outsource production.
It has been extremely well managed for the past couple of years.
I'm also underwater by over 50% and could take the position of disgruntled shareholder, but I'm more optimistic today than anytime previously.
The current MC is around $12.5m. That could double or triple overnight if they can pull off a couple of more deals comparable to the Hawkei contract.
Our 2 major shareholders would be under-water by a significant margin. They have both shown undying faith in the technology that the company possesses (and protects). I've followed their lead in recent times and would not be surprised to see a couple of more serious investors jump on board in the upcoming weeks.
ABV Price at posting:
3.3¢ Sentiment: Buy Disclosure: Held
